Vicky Kumar: How Best to Manage Patients with Patent Foramen Ovale After a Cryptogenic Stroke
Vicky Kumar, Research Fellow at The George Washington University, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”’Pill or Plug? Rethinking Secondary Stroke Prevention for PFO Patients’
In this review, we explore one of the most debated topics in stroke prevention—how best to manage patients with patent foramen ovale (PFO) after a cryptogenic stroke.
We dive into:
- Medical therapy (antiplatelets vs anticoagulants)
- Transcatheter PFO closure and evolving device technologies
- Key clinical trials shaping current practice
- Risk stratification tools like RoPE and PASCAL
- The importance of personalized, patient-centered decision-making
Our key takeaway: there is no ‘one-size-fits-all; approach—optimal management depends on careful patient selection, balancing benefits with potential risks such as atrial fibrillation.
Grateful to collaborate with an amazing team of co-authors across institutions.
This work reinforces the importance of integrating cardiology and neurology perspectives to improve outcomes in stroke care.”
Title: Pill or plug? Rethinking secondary stroke prevention for PFO patients
Authors: Roshni Memon, Umar Aziz, Hamama Waseem, Muqadas Bhatti, Javeria Nawaz, Muhammad Waaiz, Raghabendra Kumar Mahato, Vicky Kumar, Haris Muhammad
Read the Full Article on Annals of Medicine and Surgery
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 26, 2026, 15:47Edward Lee Carter: Are All DOACs Truly Interchangeable in Real-World Practice?
-
Mar 26, 2026, 15:46Faizan Khan: Key Findings on Long Term Stroke Risk After TIA and Minor Stroke
-
Mar 26, 2026, 15:441 in 4 Will Have a Stroke, It is More Common than People Think and It Does Not Discriminate – European Stroke Organisation
-
Mar 26, 2026, 15:39Fabrice Cognasse: Platelets May Play a Much Broader Role in Regulating Inflammation
-
Mar 26, 2026, 15:27Maxime Dely: Anticoagulant Is an Invisible Yet Essential Ally of Therapeutic Apheresis
-
Mar 26, 2026, 15:24Colleen Silk: Fueling Innovation in Rare Bleeding Disorders at THSNA 2026
-
Mar 26, 2026, 15:19Wolfgang Miesbach: A Remarkable Progress With Non-Factor Therapies in Hemophilia Care
-
Mar 26, 2026, 15:19Attilio Cotroneo: Updated Evidence-Based Recommendations for the Management of BTAI
-
Mar 26, 2026, 15:14Rodrigo Assar: Thrombosis Risk Prediction in Pediatric Central Lines